HIF1A and breast carcinoma: Collectively, we first determined the synergistic anti‐cancer effects of PD and 2‐DG coutreatment and found that the effect was mediated by the ROS/PI3K/AKT/HIF1α/HK2 and glycolysis pathways in breast cancer.